HME volume remains steady while hospice deals fall. Home health agency mergers and acquisitions seem to reflect the industry's return to health.
HHA deals rose from 45 in 2003 to a record 57 deals in 2004, say M&A experts The Braff Group in a recent report. Private buyers made 75 percent of the transactions, the Pittsburgh-based firm says. Publicly traded HHA companies are favoring their own start-ups over acquisitions, Braff notes.
Home medical equipment deals led the home care market with 90 transactions in 2004, up slightly from 86 in 2003, according to the report. Hospice M&A was down from 17 deals in 2003 to 15 deals last year.
CMS this week updated its power wheelchair coding announcement, noting that the handful of manufacturers with internal testing facilities that meet ANSI/RESNA standards may perform a self-test on their equipment.
"Senior management attestation to the qualifications of the internal testing facility will be required," the update states. And the results will be subject to validation by the statistical analysis durable medical equipment regional carrier. The update notice is at
Hospice advocates argue the cut actually will increase Medicaid costs by pushing beneficiaries into hospitals and emergency rooms.
According to the state's Medicaid supplier manual, suppliers must be certified by the Rehabilitation Engineering Society of North America or an "accepted equivalent," such as the Certified Rehab Technology Supplier credential from the National Registry of Rehab Technology Suppliers.
More information is at
The Orlando, FL-based respiratory and DME provider reported net earnings of $38.2 million for fiscal year 2004 on revenue of $534.5 million. That compares to net earnings of $8.4 million on revenues of $581.2 million in the previous year. Respiratory therapy equipment and services accounted for 86.6 percent of the company's 2004 revenues, while DME made up 12.2 percent.
The jury verdicts against Stephanie Smith and Miraidy Gonzalez bring to 12 the number of persons convicted in the case, according to the office of U.S. Attorney Marcos Daniel Jimnez. The scheme allegedly involved DME companies paying kickbacks and fraudulently billing Medicare for custom orthotic devices and other medical equipment and services.
Smith owned a medical clinic and supplied false prescriptions used in the scheme, while Gonzalez worked at a billing company that created fake patient files and submitted the false claims to Medicare.